|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.88 CNY | -1.31% |
|
-3.99% | -15.90% |
| Dec. 12 | Guangdong Marubi Biotechnology submits Hong Kong listing application | RE |
| Nov. 12 | Guangdong Marubi Biotechnology to Launch Hong Kong IPO | MT |
| Capitalization | 11.18B 1.63B 1.41B 1.27B 1.21B 2.21B 150B 2.28B 15.01B 5.98B 71.79B 6.11B 5.98B 259B | P/E ratio 2025 * |
28.7x | P/E ratio 2026 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise value | 10.17B 1.48B 1.28B 1.16B 1.1B 2.01B 137B 2.07B 13.66B 5.44B 65.3B 5.56B 5.44B 235B | EV / Sales 2025 * |
2.78x | EV / Sales 2026 * | 2.28x |
| Free-Float |
19.2% | Yield 2025 * |
1.75% | Yield 2026 * | 2.1% |
| 1 day | -1.31% | ||
| 1 week | -3.99% | ||
| Current month | -7.93% | ||
| 1 month | -14.97% | ||
| 3 months | -18.93% | ||
| 6 months | -30.23% | ||
| Current year | -15.90% |
| 1 week | 27.68 |  | 28.53 |
| 1 month | 27.68 | | 33.04 |
| Current year | 27.68 | | 35.5 |
| 1 year | 27.68 | | 56.98 |
| 3 years | 20.17 | | 56.98 |
| 5 years | 19.1 | | 62.26 |
| 10 years | 19.1 | | 92.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Huai Qing Sun
CEO | Chief Executive Officer | 57 | 2015-12-31 |
Kai Hui Wang
DFI | Director of Finance/CFO | 55 | 2021-02-28 |
Chao Wan Guo
CTO | Chief Tech/Sci/R&D Officer | 43 | 2019-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Huai Qing Sun
CHM | Chairman | 57 | 2015-12-31 |
Kai Hui Wang
BRD | Director/Board Member | 55 | 2015-12-31 |
Ling Chun Zeng
BRD | Director/Board Member | 48 | 2018-04-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31% | -3.99% | -16.25% | -28.53% | 1.65B | |
| -0.32% | -0.51% | -0.71% | -3.18% | 226B | |
| -2.33% | +5.01% | +56.44% | - | 46.72B | |
| +0.27% | -1.44% | -0.79% | +25.44% | 18.06B | |
| -2.38% | -2.31% | +6.20% | -51.43% | 7.78B | |
| +1.32% | -5.56% | +14.42% | +2.75% | 5.48B | |
| -0.67% | -1.41% | +7.98% | +14.92% | 4.75B | |
| +0.29% | +0.99% | -18.02% | -47.42% | 3.92B | |
| +1.22% | +3.74% | +46.85% | +103.14% | 2.93B | |
| -0.13% | -1.68% | -26.15% | -29.78% | 3.01B | |
| Average | -0.57% | +0.77% | +7.00% | -1.57% | 32B | |
| Weighted average by Cap. | -0.83% | +0.90% | +8.09% | -2.17% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.66B 533M 460M 416M 398M 725M 49.14B 745M 4.91B 1.96B 23.5B 2B 1.96B 84.63B | 4.46B 649M 561M 506M 484M 882M 59.84B 907M 5.98B 2.39B 28.61B 2.43B 2.38B 103B |
| Net income | 389M 56.66M 48.96M 44.2M 42.27M 77.05M 5.22B 79.22M 522M 208M 2.5B 213M 208M 9B | 489M 71.25M 61.57M 55.58M 53.16M 96.9M 6.57B 99.62M 657M 262M 3.14B 267M 262M 11.32B |
| Net Debt | -1.01B -147M -127M -115M -110M -200M -13.56B -206M -1.36B -541M -6.48B -552M -540M -23.36B | -1B -146M -126M -114M -109M -198M -13.44B -204M -1.34B -536M -6.43B -547M -536M -23.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-10 | 27.88 ¥ | -1.31% | 2,302,405 |
| 26-03-10 | 28.25 ¥ | +1.25% | 2,086,000 |
| 26-03-09 | 27.90 ¥ | -1.76% | 2,218,600 |
| 26-03-06 | 28.40 ¥ | +0.89% | 1,660,700 |
| 26-03-05 | 28.15 ¥ | -0.11% | 2,042,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 603983 Stock
Select your edition
All financial news and data tailored to specific country editions
